Director of Business Development, Roebling

Enterprise

$210-230k

OTE

$150-170k

BASE

+ Competitive compensation packages, including equity

Senior and Expert level

Boston

New York

San Francisco Bay Area

Remote from US

More information about location

AI-powered development stack for industrial infrastructure

Job no longer available

AI-powered development stack for industrial infrastructure

21-100 employees

B2BSustainabilityInvestingBiologyEnvironmentalScience

Job no longer available

$210-230k

OTE

$150-170k

BASE

+ Competitive compensation packages, including equity

Senior and Expert level

Boston

New York

San Francisco Bay Area

Remote from US

More information about location

21-100 employees

B2BSustainabilityInvestingBiologyEnvironmentalScience

Company mission

To enable the rapid development of the industrial infrastructure required to power and manufacture cutting-edge technologies.

Job

Company

Role

Who you are

Enterprise Sales Expert: 7-10 years of success selling enterprise software, SaaS, or complex technology to VP-level and above in biotech, biomanufacturing, specialty chemicals, or related industries
Biomanufacturing Knowledgeable: Familiar with scaling bioprocesses, techno-economic modeling, and cost analysis, enabling credibility with technical and executive stakeholders
Self-Starter & Entrepreneurial: Thrives in fast-paced startups, takes ownership, and consistently drives results with minimal oversight
Strategic Communicator: Builds trust with enterprise buyers, translating complex technical and economic concepts into clear, compelling value propositions
Analytical & Insightful: Uses data-driven insights to prioritize opportunities, demonstrate ROI, and navigate complex sales discussions

What the job involves

We're looking for an experienced, entrepreneurial, and highly motivated Director of Business Development to lead enterprise sales for our Platform business, with a focus on Scaler - a dynamic techno-economic modeling software that empowers companies to confidently evaluate, launch, and improve biobased products
Scaler enables comprehensive production and financial analysis through customized modeling specific to a company’s bioprocess, and leverages Synonym’s deep biomanufacturing expertise from veterans of Jacobs, Merrick, Cargill, and DuPont, ensuring unmatched accuracy and data integrity
The Director of Business Development will report directly to the GM, Platform and collaborate closely across internal teams
Develop and execute a targeted go-to-market strategy for Scaler, specifically focused on large corporations actively exploring commercial biomanufacturing solutions
Identify, prospect, and engage senior decision-makers, leveraging existing relationships and strategic outreach to drive the adoption of Scaler
Clearly communicate Scaler’s value proposition, demonstrating how our modeling software uniquely addresses enterprise customer needs for accurate, flexible, and robust biomanufacturing cost analysis
Build long-term relationships by understanding customer pain points, translating these insights into compelling proposals, and negotiating successful agreements
Act as the voice of the customer internally, providing valuable feedback to enhance Scaler’s features, user experience, and market positioning
Collaborate closely with cross-functional Synonym teams (product, technical, legal) to ensure customer satisfaction, seamless onboarding, and ongoing support

Our take

Formerly Synonym, a biomanufacturing company, Roebling was founded on the experiences of its staff in building and financing its industrial projects. Specifically, siloed processes and a lack of integrated tools at the disposal of Synonym meant that project speed and flexibility were hindered. It’s for this reason that in 2026, Roebling expanded its predecessor's biomanufacturing remit into the wider industrial landscape and now acts as a platform for industrial process engineers.

Its tools include techno-economic analysis, process design and cost estimation, helping industrial project stakeholders to accelerate project timelines through data analysis. Reportedly, a first-of-its-kind platform, Roebling is deftly utilizing its years of prior experience to help biomanufacturing, food and agriculture, critical minerals, chemicals and energy projects to speed up their processes.

With a back catalogue of Fortune 500 companies served under Synonym, it will be interesting to see how Roebling expands its customer base and utilises its preexisting partnerships.

Kirsty

Company Specialist at Welcome to the Jungle

Company

Funding (2 rounds)

Aug 2024

$1.9m

GRANT

Oct 2022

$6.3m

SEED

Total funding: $8.2m

Company benefits

Comprehensive medical, dental, and vision coverage
Daily lunch allowance
Coworking space (NYC, Boston, SF Bay Area)
Competitive compensation packages, including equity
Flexible PTO
401(k)
Team offsites

Company HQ

Civic Center, New York, NY

Leadership

Edward Shenderovich

(Co-Founder & CEO)

Before co-founding Roebling, founded Essential Capital, Knotel and Merchantry. Was Head of Strategic Development at SUP Media and CEO of Quantum Art.

Joshua Lachte

(Co-Founder & CBO)

Previously Vice President at ASAPP and Director of Operations with Greenmantle. Before that, they were a Founding Associate at Locus Analytics.

Brentan Alexander

(Co-Founder & CTO)

Is also a Partner at Tuatara Advisory, was the Founder & Director of EnergyFolks, was the President of New Energy Risk and the Founder & CEO of Swift Calcs.

Salary benchmarks

We don't have enough data yet to provide salary benchmarks for this role.

Submit your salary to help other candidates with crowdsourced salary estimates.

Share this job

View 2 more jobs at Roebling